Terms: = Prostate cancer AND BCL6, BCL5, 603, 604, ENSG00000113916, ZBTB27, P41182, LAZ3, BCL6A, ZNF51 AND Treatment
77 results:
1. Medication-based Comorbidity Measures and prostate cancer treatment Selection.
Tiruye T; O'Callaghan M; FitzGerald LM; Moretti K; Jay A; Higgs B; Kichenadasse G; Caughey G; Roder D; Beckmann K
Clin Genitourin Cancer; 2024 Apr; 22(2):599-609.e2. PubMed ID: 38369388
[TBL] [Abstract] [Full Text] [Related]
2. Transcriptional Inflammatory Signature in Healthy Donors and Different Radiotherapy cancer Patients.
O'Brien G; Kamuda M; Cruz-Garcia L; Polozova M; Tichy A; Markova M; Sirak I; Zahradnicek O; Widłak P; Ponge L; Polanska J; Badie C
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256152
[TBL] [Abstract] [Full Text] [Related]
3. Safer and More Convenient Modern Curative Radiotherapy for Patients With Early prostate cancer.
Reinikainen P; Lehtinen I; Luukkaala T; Kellokumpu-Lehtinen PL
Anticancer Res; 2024 Jan; 44(1):139-150. PubMed ID: 38159980
[TBL] [Abstract] [Full Text] [Related]
4. S-adenosylmethionine treatment affects histone methylation in prostate cancer cells.
Mathes A; Duman MB; Neumann A; Dobreva G; Schmidt T
Gene; 2024 Jan; 893():147915. PubMed ID: 37866662
[TBL] [Abstract] [Full Text] [Related]
5. Pain and its interference with daily living in relation to cancer: a comparative population-based study of 16,053 cancer survivors and 106,345 people without cancer.
Joshy G; Khalatbari-Soltani S; Soga K; Butow P; Laidsaar-Powell R; Koczwara B; Rankin NM; Brown S; Weber M; Mazariego C; Grogan P; Stubbs J; Thottunkal S; Canfell K; Blyth FM; Banks E
BMC Cancer; 2023 Sep; 23(1):774. PubMed ID: 37700229
[TBL] [Abstract] [Full Text] [Related]
6. prostate cancer detection and segmentation on MRI using non-local mask R-CNN with histopathological ground truth.
Dai Z; Jambor I; Taimen P; Pantelic M; Elshaikh M; Dabaja A; Rogers C; Ettala O; Boström PJ; Aronen HJ; Merisaari H; Wen N
Med Phys; 2023 Dec; 50(12):7748-7763. PubMed ID: 37358061
[TBL] [Abstract] [Full Text] [Related]
7. Comparing Risk for Second Primary cancers After Intensity-Modulated vs 3-Dimensional Conformal Radiation Therapy for prostate cancer, 2002-2015.
Pithadia KJ; Advani PG; Citrin DE; Bekelman JE; Withrow DR; Berrington de Gonzalez A; Morton LM; Schonfeld SJ
JAMA Oncol; 2023 Aug; 9(8):1119-1123. PubMed ID: 37289449
[TBL] [Abstract] [Full Text] [Related]
8. Cost-effectiveness analysis of primary treatments for localised prostate cancer: A population-based Markov analysis using real-world evidence.
Weng X; Zhong L; Xiang P; Li Y; Paciorek A; Dong L; Broering J; Carroll PR; Sanda M; Wilson L
Eur J Cancer Care (Engl); 2022 Nov; 31(6):e13740. PubMed ID: 36239065
[TBL] [Abstract] [Full Text] [Related]
9. Health-related Quality of Life of Patients Treated With Different Fractionation Schedules for Early prostate cancer Compared to the Age-standardized General Male Population.
Reinikainen P; Lehtonen M; Lehtinen I; Luukkaala T; Sintonen H; Kellokumpu-Lehtinen PL
Clin Genitourin Cancer; 2023 Feb; 21(1):146-154. PubMed ID: 36038484
[TBL] [Abstract] [Full Text] [Related]
10. Disparities in Survival and Comorbidity Burden Between Asian and Native Hawaiian and Other Pacific Islander Patients With cancer.
Taparra K; Qu V; Pollom E
JAMA Netw Open; 2022 Aug; 5(8):e2226327. PubMed ID: 35960520
[TBL] [Abstract] [Full Text] [Related]
11. Mapping cancer in Africa: A Comprehensive and Comparable Characterization of 34 cancer Types Using Estimates From GLOBOCAN 2020.
Sharma R; Aashima ; Nanda M; Fronterre C; Sewagudde P; Ssentongo AE; Yenney K; Arhin ND; Oh J; Amponsah-Manu F; Ssentongo P
Front Public Health; 2022; 10():839835. PubMed ID: 35548083
[TBL] [Abstract] [Full Text] [Related]
12. Acute Side-effects of Different Radiotherapy treatment Schedules in Early prostate cancer.
Reinikainen P; Kapanen M; Luukkaala T; Kellokumpu-Lehtinen PL
Anticancer Res; 2022 May; 42(5):2553-2565. PubMed ID: 35489724
[TBL] [Abstract] [Full Text] [Related]
13. Functional and quality of life outcomes of localised prostate cancer treatments (prostate Testing for cancer and treatment [ProtecT] study).
Lane JA; Donovan JL; Young GJ; Davis M; Walsh EI; Avery KNL; Blazeby JM; Mason MD; Martin RM; Peters TJ; Turner EL; Wade J; Bollina P; Catto JWF; Doherty A; Gillatt D; Gnanapragasam V; Hughes O; Kockelbergh R; Kynaston H; Oxley J; Paul A; Paez E; Rosario DJ; Rowe E; Staffurth J; Neal DE; Hamdy FC; Metcalfe C;
BJU Int; 2022 Sep; 130(3):370-380. PubMed ID: 35373443
[TBL] [Abstract] [Full Text] [Related]
14. Multi-criteria optimization for planning volumetric-modulated arc therapy for prostate cancer.
Park J; Park J; Oh S; Yea JW; Lee JE; Park JW
PLoS One; 2021; 16(9):e0257216. PubMed ID: 34506581
[TBL] [Abstract] [Full Text] [Related]
15. Efficacy, safety and tolerability of drugs studied in phase 3 randomized controlled trials in solid tumors over the last decade.
Ribnikar D; Goldvaser H; Veitch ZW; Ocana A; Templeton AJ; Šeruga B; Amir E
Sci Rep; 2021 May; 11(1):10843. PubMed ID: 34035370
[TBL] [Abstract] [Full Text] [Related]
16. Comparison of Mexican-American vs Caucasian prostate cancer active surveillance candidates.
Collà Ruvolo C; Stolzenbach LF; Nocera L; Deuker M; Mistretta FA; Luzzago S; Tian Z; Longo N; Graefen M; Chun FKH; Saad F; Briganti A; De Cobelli O; Mirone V; Karakiewicz PI
Urol Oncol; 2021 Jan; 39(1):74.e1-74.e7. PubMed ID: 32950397
[TBL] [Abstract] [Full Text] [Related]
17. Lead-time bias does not falsify the efficacy of early salvage radiotherapy for recurrent prostate cancer.
Bartkowiak D; Thamm R; Siegmann A; Böhmer D; Budach V; Wiegel T
Radiother Oncol; 2021 Jan; 154():255-259. PubMed ID: 32920006
[TBL] [Abstract] [Full Text] [Related]
18. Is prostate brachytherapy a dying art? Trends and variation in the definitive management of prostate cancer in Ontario, Canada.
Corkum MT; Morton G; Louie AV; Bauman GS; Mendez LC; Chin J; D'Souza DP; Dinniwell RE; Velker VM; Saskin R; Warner A; Rodrigues GB
Radiother Oncol; 2020 Nov; 152():42-48. PubMed ID: 32717361
[TBL] [Abstract] [Full Text] [Related]
19. treatment of Urinary Incontinence in Patients With Erectile Dysfunction.
Ajay D; Mendez MH; Wang R; Westney OL
Sex Med Rev; 2021 Oct; 9(4):593-604. PubMed ID: 32622885
[TBL] [Abstract] [Full Text] [Related]
20. Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA.
Bharadwaj A; Potts J; Mohamed MO; Parwani P; Swamy P; Lopez-Mattei JC; Rashid M; Kwok CS; Fischman DL; Vassiliou VS; Freeman P; Michos ED; Mamas MA
Eur Heart J; 2020 Jun; 41(23):2183-2193. PubMed ID: 31800032
[TBL] [Abstract] [Full Text] [Related]
[Next]
